New York Intellectual Property Cases
Cases 21 - 25 of 25
Indivior, Inc et al v. Par Pharmaceutical, Inc.
as 7:2017cv07020
Plaintiff:
Indivior, Inc and Indivior UK Limited
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Valeant Pharmaceuticals International, Inc. et al
as 1:2017cv06557
Plaintiff:
Valeant Pharmaceuticals International, Inc. , Salix Pharmaceuticals, Inc. , Progenics Pharmaceuticals, Inc. and others
Defendant:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo International PLC
Cause Of Action: 18 U.S.C. § 1341
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2017cv05405
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. , Taro Pharmaceuticals U.S.A., Inc. and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Par Pharmaceutical, Inc.
as 1:2017cv04984
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Kowa Company, Ltd. et al v. Hetero Drugs Limited et al
as 1:2017cv04421
Plaintiff:
Kowa Company, Ltd. , Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, Ltd.
Defendant:
Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
